“Novel Inhibitors of Malarial Aspartyl Proteases, Plasmepsin II and IV: In Silico Design and Validation Studies”. 2022. Chemical Biology Letters 9 (1): 315. https://pubs.thesciencein.org/journal/index.php/cbl/article/view/315.